Join Jorge E. Cortes, MD and Neil Shah, MD, PhD and participate in an interactive case-based review of current clinical issues and emerging treatment paradigms in the management of patients with CML.
Treatment Approaches in Relapsed CML
Jorge Eduardo Cortes, MD
MD Anderson Cancer Center
Topics include:
Sub-optimal responses
Criteria for failure to imatinib
Second generation TKIs
Novel Agents
Treatment of Newly Diagnosed CML Mechanisms of Imatinib Resistance
Neil Shah, MD, PhD
University of California, San Francisco School of Medicine
Topics include:
Primary treatment strategies
Response evaluation
Monitoring strategies
Mechanisms of resistance
Available until March 2009, this activity offers:
Physicians: 1.5 AMA PRA Category 1 Credits™
Nurses: 1.5 contact hours
Pharmacists: 1.5 contact hours (0.15 CEUs)
This activity is made possible by an educational grant from:
